BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34461283)

  • 1. Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease.
    Yasutomi Y; Chiba A; Haga K; Murayama G; Makiyama A; Kuga T; Watanabe M; Okamoto R; Nagahara A; Nagaishi T; Miyake S
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):81-93. PubMed ID: 34461283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
    Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
    J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus.
    Murayama G; Chiba A; Suzuki H; Nomura A; Mizuno T; Kuga T; Nakamura S; Amano H; Hirose S; Yamaji K; Suzuki Y; Tamura N; Miyake S
    Front Immunol; 2019; 10():2681. PubMed ID: 31849932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
    Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
    Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.
    Ju JK; Cho YN; Park KJ; Kwak HD; Jin HM; Park SY; Kim HS; Kee SJ; Park YW
    J Innate Immun; 2020; 12(5):422-434. PubMed ID: 32535589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal-Associated Invariant T Cells Are Involved in Acute Ischemic Stroke by Regulating Neuroinflammation.
    Nakajima S; Tanaka R; Yamashiro K; Chiba A; Noto D; Inaba T; Kurita N; Miyamoto N; Kuroki T; Shimura H; Ueno Y; Urabe T; Miyake S; Hattori N
    J Am Heart Assoc; 2021 Apr; 10(7):e018803. PubMed ID: 33733818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1.
    Yan J; Allen S; McDonald E; Das I; Mak JYW; Liu L; Fairlie DP; Meehan BS; Chen Z; Corbett AJ; Varelias A; Smyth MJ; Teng MWL
    Cancer Discov; 2020 Jan; 10(1):124-141. PubMed ID: 31826876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.
    Kawachi I; Maldonado J; Strader C; Gilfillan S
    J Immunol; 2006 Feb; 176(3):1618-27. PubMed ID: 16424191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis.
    Chiba A; Tajima R; Tomi C; Miyazaki Y; Yamamura T; Miyake S
    Arthritis Rheum; 2012 Jan; 64(1):153-61. PubMed ID: 21904999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
    Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
    J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal-associated invariant T cells display both pathogenic and protective roles in patients with inflammatory bowel diseases.
    Wei L; Chen Z; Lv Q
    Amino Acids; 2023 Dec; 55(12):1819-1827. PubMed ID: 37819474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAIT cells and the microbiome.
    Jabeen MF; Hinks TSC
    Front Immunol; 2023; 14():1127588. PubMed ID: 36911683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of mucosal-associated invariant T cells and their roles in immune diseases.
    Chiba A; Murayama G; Miyake S
    Int Immunol; 2021 Nov; 33(12):775-780. PubMed ID: 34508634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the temporal development of Alzheimer's disease pathology by the MR1/MAIT cell axis.
    Wyatt-Johnson SK; Kersey HN; Codocedo JF; Newell KL; Landreth GE; Lamb BT; Oblak AL; Brutkiewicz RR
    J Neuroinflammation; 2023 Mar; 20(1):78. PubMed ID: 36944969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Hiejima E; Kawai T; Nakase H; Tsuruyama T; Morimoto T; Yasumi T; Taga T; Kanegane H; Hori M; Ohmori K; Higuchi T; Matsuura M; Yoshino T; Ikeuchi H; Kawada K; Sakai Y; Kitazume MT; Hisamatsu T; Chiba T; Nishikomori R; Heike T
    Inflamm Bowel Dis; 2015 Jul; 21(7):1529-40. PubMed ID: 25946569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization.
    Li Y; Huang B; Jiang X; Chen W; Zhang J; Wei Y; Chen Y; Lian M; Bian Z; Miao Q; Peng Y; Fang J; Wang Q; Tang R; Gershwin ME; Ma X
    Front Immunol; 2018; 9():1994. PubMed ID: 30233587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
    Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
    J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain astrocytes and microglia express functional MR1 molecules that present microbial antigens to mucosal-associated invariant T (MAIT) cells.
    Priya R; Brutkiewicz RR
    J Neuroimmunol; 2020 Dec; 349():577428. PubMed ID: 33096293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells.
    Huang S; Gilfillan S; Kim S; Thompson B; Wang X; Sant AJ; Fremont DH; Lantz O; Hansen TH
    J Exp Med; 2008 May; 205(5):1201-11. PubMed ID: 18443227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
    Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
    Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.